Idorsia Ltd. (IDRSF)
6.15
0.00 (0.00%)
USD |
OTCM |
Sep 11, 16:00
Idorsia Price : 6.15 for Sept. 11, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 11, 2026 | 6.15 | 6.15 | 6.15 | 6.15 | 0.000 |
| Sep 10, 2026 | 6.15 | 6.15 | 6.15 | 6.15 | 2000.00 |
| Sep 09, 2026 | 6.27 | 6.27 | 6.27 | 6.27 | 8.000 |
| Sep 08, 2026 | 6.31 | 6.31 | 6.27 | 6.27 | 2000.00 |
| Sep 04, 2026 | 6.24 | 6.24 | 6.24 | 6.24 | 0.000 |
| Sep 03, 2026 | 6.24 | 6.24 | 6.24 | 6.24 | 400.00 |
| Sep 02, 2026 | 6.25 | 6.25 | 6.25 | 6.25 | 2000.00 |
| Sep 01, 2026 | 6.50 | 6.50 | 6.50 | 6.50 | 0.000 |
| Aug 31, 2026 | 6.90 | 6.90 | 6.50 | 6.50 | 30938.00 |
| Aug 28, 2026 | 7.25 | 7.25 | 7.25 | 7.25 | 0.000 |
| Aug 27, 2026 | 7.25 | 7.25 | 7.25 | 7.25 | 0.000 |
| Aug 26, 2026 | 7.25 | 7.25 | 7.25 | 7.25 | 0.000 |
| Aug 25, 2026 | 7.25 | 7.25 | 7.25 | 7.25 | 0.000 |
| Aug 24, 2026 | 7.25 | 7.25 | 7.25 | 7.25 | 0.000 |
| Aug 21, 2026 | 7.25 | 7.25 | 7.25 | 7.25 | 13000.00 |
| Aug 20, 2026 | 7.31 | 7.31 | 7.31 | 7.31 | 302.00 |
| Aug 19, 2026 | 7.31 | 7.31 | 7.31 | 7.31 | 0.000 |
| Aug 18, 2026 | 7.31 | 7.31 | 7.31 | 7.31 | 1000.00 |
| Aug 17, 2026 | 7.75 | 7.75 | 7.75 | 7.75 | 0.000 |
| Aug 14, 2026 | 7.75 | 7.75 | 7.75 | 7.75 | 0.000 |
| Aug 13, 2026 | 8.00 | 8.00 | 7.75 | 7.75 | 2850.00 |
| Aug 12, 2026 | 7.90 | 7.90 | 7.90 | 7.90 | 4625.00 |
| Aug 11, 2026 | 7.90 | 7.90 | 7.90 | 7.90 | 9736.00 |
| Aug 10, 2026 | 6.95 | 6.95 | 6.95 | 6.95 | 0.000 |
| Aug 07, 2026 | 6.95 | 6.95 | 6.95 | 6.95 | 0.000 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Basilea Pharmaceutica AG | 77.40 |
| Santhera Pharmaceuticals Holding AG | 19.79 |
| BeOne Medicines Ltd. | 354.47 |
| AC Immune SA | 2.67 |
| CRISPR Therapeutics AG | 52.82 |
Price Related Metrics
| PS Ratio | 5.927 |
| PEG Ratio | -0.0396 |
| Earnings Yield | -26.85% |
| Market Cap | 1.618B |
| PEGY Ratio | -0.0396 |